key: cord-0291043-co3jhhav authors: Sell, H.; Paudel, Y. R.; Voaklander, D.; MacDonald, S. E. title: School immunization coverage during the COVID-19 pandemic: A retrospective cohort study date: 2022-05-07 journal: nan DOI: 10.1101/2022.05.04.22274665 sha: c1d9fbf352c70899baa96070c968e0aa2c8861d3 doc_id: 291043 cord_uid: co3jhhav Few studies have assessed the impact of the COVID-19 pandemic on immunization coverage for adolescents, and little is known about how coverage has changed throughout the pandemic. We aimed to: (1) assess the change in coverage for school-based vaccines in Alberta, Canada resulting from the pandemic; (2) determine whether coverage differed by geographic health zone and school type; and (3) ascertain whether coverage has returned to pre-pandemic levels. Using a retrospective cohort design, we used administrative health data to compare coverage for human papillomavirus (HPV) and meningococcal conjugate A, C, Y, W-135 (MenC-ACYW) vaccines in Alberta, Canada between pre-pandemic (2017-2018 school year) and pandemic (2019-2020 and 2020-2021 school years) cohorts (N=289,420). Coverage was also compared by health zone and authority type. The 2019-2020 cohort was followed over one year to assess catch-up. Compared to 2017-2018, immunization coverage for HPV was significantly lower in the 2019-2020 (absolute difference: 60.8%; 95% CI: 60.4-61.3%) and 2020-2021 cohorts (absolute difference: 59.9%; 95% CI: 59.4-60.3%). There was a smaller, significant decline in MenC-ACYW coverage comparing 2017-2018 to 2019-2020 (absolute difference: 6.1%; 95% CI: 5.6-6.5%) and 2020-2021 (absolute difference: 32.2%; 95% CI: 31.6-32.7%). Private schools had low coverage overall, while coverage fluctuated by zone. During follow-up of the 2019-2020 cohort, coverage for HPV and MenC-ACYW increased from 5.6% to 50.2%, and 80.7% to 83.0%, respectively. There was a substantial decrease in school-based immunization coverage during the COVID-19 pandemic, and coverage has not returned to pre-pandemic levels, suggesting further catch-up is needed. The COVID-19 pandemic has greatly impacted health care systems worldwide via COVID-19related hospitalizations, testing and tracing programs, and the introduction of mass COVID-19 immunization campaigns. As a result, many routine health services may have been overlooked, including immunization. There has been mounting concern among public health experts and health care providers regarding global declines in routine childhood immunization coverage during the pandemic. 1 In Canada, public health restrictions began in mid-March 2020, including physical distancing measures, school and clinic closures, and re-allocation of public health staff. 4 These restrictions may have disrupted routine immunization programs, leaving many Canadian children with missed immunization doses. 5,6 Immunizations for school-aged children have likely been significantly disrupted as national recommendations have prioritized infant vaccines, while school-based immunization programs were suspended due to school closures. 5, 7 As such, there is concern that the reduction in coverage for adolescent vaccines will increase susceptibility to vaccine-preventable diseases. 5, 8 Few studies have assessed the impact of the COVID-19 pandemic on immunization coverage for adolescents. For instance, two U.S. studies reported significant declines in immunization rates for adolescents in the early pandemic period (March-May 2020). 2, 3 However, no studies to date have examined how coverage for adolescent vaccines has changed throughout the pandemic. It is essential to quantify the impact of the pandemic on routine immunization coverage and determine whether coverage recovered during the pandemic, as this information can assist public health in identifying populations of children with missed immunizations and devising strategies for catch-up to prevent future disease outbreaks. As such, the objective of this study was to assess the change in immunization coverage resulting from the COVID-19 pandemic for two All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint school-based vaccines (human papillomavirus [HPV] and meningococcal A, C, Y, W-135 [MenC-ACYW]) and ascertain whether coverage has returned to pre-pandemic levels. Additionally, we sought to determine whether immunization coverage during the pandemic differed by factors such as geographic health zone and school type. This was a retrospective cohort study of immunization coverage for two school-based vaccines using administrative health data. The study took place in Alberta, a western Canadian province with a population of approximately 4.5 million. 9 The province is divided into five geographical health zones (North, South, and Central, which are predominantly rural zones, and Calgary and Edmonton, which are large urban zones) for the purpose of publicly funded health service delivery, including immunizations. 10 Routinely scheduled immunizations for adolescents are usually administered by public health nurses through school-based programs. 11 Table A1 in the appendix provides more information on the number and timing of doses for school-based immunizations in Alberta. The dataset was created by linking population-based administrative databases from the Alberta Ministry of Health, including Alberta Health Care Insurance Plan (AHCIP), Provincial School Immunization Record (PSIR), and Immunization and Adverse Reaction to Immunization (Imm/ARI). Almost all Albertans (99%) are registered in the AHCIP, which assigns them a unique lifetime identifier that was used to link administrative health records for each individual, including their immunization records. During the period of this study, the Imm/ARI database included all publicly funded childhood vaccines administered in Alberta, except those described in exclusions below. The PSIR database contains individual-level records of student enrollment information in each school year, including grade, age, and sex, as well as school-level information such as geographic health zone and authority type. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Exclusions were those who died or migrated out of Alberta during each respective school year, identified as First Nations (Canada's largest population of Indigenous Peoples, who were excluded because their data is not consistently submitted to Imm/ARI and PSIR), or were from Lloydminster (as vaccines are delivered by a neighbouring province). Additionally, schools that offer online or distance education (not due to COVID-19), post-secondary, continuing education, summer, or evening/weekend schools were also excluded. To be consistent with previous coverage analyses, 12 age limitations were also applied for each grade: for grade 5, those <9 years of age and >11 years were excluded from the analysis; for grade 6, those <10 years and >12 years were excluded; for grade 9, those <13 years and >15 years were excluded. Figures A1 and A2 in the appendix provide further details on exclusions. Immunization coverage 13 was defined as the proportion of age-and grade-eligible children who received a complete vaccine series on or prior to July 31 of each school year for two vaccines, HPV and MenC-ACYW. Currently, a complete vaccine series for HPV consists of two doses given in grade 6, while MenC-ACYW is a single dose given in grade 9. There was no school program for HPV immunization in the 2018-2019 school year due to a change in delivery from three doses in grade 5 to two doses in grade 6, 14 so the 2017-2018 school year was used as the pre-pandemic comparison year. As a three-dose program was in the place throughout 2017-2018, receipt of at least three doses was used to define a complete HPV series for this cohort. As some students may have received more doses than required, a complete series was defined as receiving the number of required doses as a minimum. Coverage was calculated as the number of children who had received a complete dose series of HPV (at least two doses in 2019-2020 or 2020-2021 and at least three doses in 2017-2018) or MenC-ACYW (at least one dose) vaccines divided by the number of children who had a record in PSIR of attending grade 5, 6, or 9 between September 1 and July 31. Absolute differences in coverage between the pre-pandemic (2017-2018 school year) and pandemic (2019-2020 and 2020-2021 school years) cohorts for each vaccine and associated 95% confidence intervals (CIs) were calculated and compared using Pearson's chi-square tests. Coverage was also stratified by geographic health zone (i.e., Calgary, Edmonton, Central, North, South) based on school location, and school authority type (i.e., public, publicly-funded Catholic, private, charter, francophone). Crude RRs and 95% CIs were All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint calculated for the analysis stratified by the geographic health zone (reference: Calgary) and authority type (reference: public); the zone and authority type with the largest populations were chosen as reference categories. A small number of participants (<1%) had missing data for the zone variable but were still included in the cohorts as no other data were missing. To assess catch-up over time for both HPV and MenC-ACYW, children who were due to be vaccinated in the 2019-2020 school year were followed until September 1, 2021. Absolute differences in coverage and 95% CIs were calculated for each vaccine after the catch-up period Table 1 describes the number of students and the sociodemographic characteristics of each cohort. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Table 2 shows HPV immunization coverage at July 31 of each pandemic school year by 8 of or or geographic health zone and school type. Across health zones, coverage ranged from 1.1% (Edmonton) to 24.7% (Central) in the 2019-2020 cohort and 0.3% (South) and 11.9% (Edmonton) in the 2020-2021 cohort. Public schools had the highest HPV coverage in both pandemic cohorts (6.6% and 7.4%), while charter and private schools had the lowest coverage in 2019-2020 and 2020-2021, respectively. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. After removing those who died or left the province before the end of the follow-up period (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. absolute difference: 6.1%; 95% CI: 5.6-6.5%; p < 0ยท001) and the 2020-2021 pandemic cohort (54.6% vs. 86.8%; absolute difference: 32.2%; 95% CI: 31.6-32.7%; p < 0.001). 12 ve ge ; All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. MenC-ACYW coverage also differed by geographic health zone and school type, but slightly less than for HPV (Table 2) . Across health zones, coverage ranged from 78.3% (Central) to 83.1% (Calgary) in 2019-2020 and 5.8% (South) to 64.0% (Central) in 2020-2021. When analyzed by school type, coverage was significantly lower in private schools in both the 2019-2020 and 2020-2021 school years (54.8% and 40.0%), and highest in charter schools in 2019-2020 (90.0%) and publicly-funded Catholic schools in 2020-2021 (57.2%). After removing those who died or left the province before the end of the follow-up period (September 1, 2021) , 45,183 children from the 2019-2020 cohort were included in the cumulative coverage analysis. As shown in Figure 5 , MenC-ACYW vaccine coverage in the 13 ic All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. When stratified by geographic health zone (Figure 6a) , all zones had steady MenC-ACYW coverage throughout the follow-up period, with Calgary having slightly higher coverage at the beginning of follow-up, and Edmonton having highest coverage at the end of follow-up. Based on school authority type (Figure 6b) , private schools had the lowest coverage for MenC-ACYW throughout the entire follow-up period, while charter schools had the highest. Public, publicly-funded Catholic, and francophone schools had similar coverage during follow-up. 14 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint Coverage was steady for all school types throughout the follow-up period. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Notes. MenC-ACYW = meningococcal A, C, Y, W-135. a Coverage defined as the percentage of children who received all scheduled doses of MenC-ACYW vaccine by the follow-up date (i.e., at least one dose). The COVID-19 pandemic has significantly impacted health care systems worldwide, including routine immunization programs. We found that HPV and MenC-ACYW immunization coverage was significantly lower in cohorts of schoolchildren who were eligible for immunization during the pandemic in comparison to before the pandemic. This decline in coverage seen during the pandemic is consistent with previous literature on other routine immunizations internationally, including infant, 3,15,16 preschool, 3,15 and adolescent. 2, 3, 17, 18 Coverage for HPV was below that of MenC-ACYW. This finding is likely explained by the fact that MenC-ACYW is a single-dose vaccine, so it was easier to complete this series before the COVID-19-related school closures, whereas the HPV series requires two doses, six months apart. Many students in both pandemic cohorts had received a single dose of HPV by the end of the school year (71.5% in the 2019-2020 and 54.5% in the 2020-2021 cohort), therefore additional follow-up efforts are needed to ensure that these partially immunized children complete the series to maximize protection against HPV. Coverage also differed by geographic health zone. Discrepancies in coverage across health zones likely reflects the epidemiology of COVID-19 in each region and the available resources to provide immunizations to schoolchildren. For example, in South zone school immunizations were delayed until the end of July 2021 due to the COVID-19 pandemic response, which may explain the lower coverage in this zone. 19 On the other hand, personal communication with public health officials in Central zone, which had higher HPV coverage (24.7%) than all other zones at the end of the 2019-2020 school year, revealed that additional immunization clinics were held at community health centres throughout June-August 2020 to catch-up students with missed doses, particularly in smaller rural sites that were not overwhelmed by COVID-19 testing. Similarly, private schools had low coverage for all vaccines in both school years in comparison to the other school types. Previous literature from Canada and the U.S. has found that private All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint schools have lower immunization coverage even prior to the pandemic. 20, 21 The differing coverage across geographic health zones and types has important implications for catch-up planning and implementation. Stratifying coverage by health zone and type may be useful for identifying where to focus catch-up immunization programs. The cumulative coverage analysis found that coverage for both HPV and MenC-ACYW To our knowledge, this study is one of the first to assess how adolescent immunization coverage has changed over time during the COVID-19 pandemic and whether it has returned to prepandemic levels. A strength of our study was the use of a population-based repository that contains complete and timely information on all childhood immunizations, as well as complete denominator data. Data were included over a one-year period to determine whether coverage was recovering to pre-pandemic levels, which was previously unknown. A limitation is that there was a change in programming for the HPV vaccine during the 2018-2019 school year, moving from three doses in grade 5 to two doses in grade 6. As there were no HPV immunizations provided in this school year, we could not use this year for comparison. This meant that our definition of fully vaccinated was three or more doses for the 2017-2018 cohort, but two or more doses for the 2019-2020 and 2020-2021 cohorts. However, the percentage of individuals with two or more doses of HPV vaccine in the 2017-2018 cohort was 74.3%, so our difference in coverage estimates based on three dose coverage are conservative and with the same direction of effect (i.e., coverage is significantly lower in the pandemic cohorts in All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint comparison to the pre-pandemic cohort). Additionally, as this study focused on immunization coverage for Albertan school children, findings may not be generalizable to other jurisdictions. Finally, as this is a descriptive analysis, we cannot be certain whether the differences in coverage seen across geographic health zones and school type can be attributed to individual, school, or zone-level factors. Further analyses are needed to understand the relationship between these factors and immunization coverage during the COVID-19 pandemic. Routine childhood immunizations are important to prevent outbreaks of vaccine-preventable diseases, which have occurred within the past decade. Additionally, individuals who miss immunizations at the scheduled time may be less likely to catch-up later. 5 In this study, coverage analyses showed that coverage for HPV and MenC-ACYW vaccines in cohorts of school children eligible for immunization during the COVID-19 pandemic declined in comparison to the pre-pandemic period. Although our findings show that some catch-up has occurred, additional efforts will be needed to ensure children are fully protected. This will require a multi-pronged approach, utilizing existing strategies such as holding additional catch-up clinics at public health centres or schools, as well as possible new strategies including providing missing routine vaccine doses at other vaccine appointments (e.g., COVID-19, influenza) 22, 23 or any contact with the health system (e.g., visits at primary care practices, pharmacies, or hospitals). 24 To date, the 2020-2021 cohort had the lowest immunization coverage, suggesting that this group may be a priority for catch-up programs. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted May 7, 2022. ; https://doi.org/10.1101/2022.05.04.22274665 doi: medRxiv preprint UNICEF warn of a decline in vaccinations duing COVID-19. World Health Organization Number of childhood and adolescent vaccinations administered before and after the COVID-19 outbreak in Colorado Association of the COVID-19 pandemic with routine childhood vaccination rates and proportion up to date with vaccinations across 8 US health systems in the Vaccine Safety Datalink National Advisory Committee on Immunization. Interim guidance on continuity of immunization programs during the COVID-19 pandemic. Government of Canada Continuity of routine immunization programs in Canada during the COVID-19 pandemic Economic dashboard. Alberta Government Immunization -school services Interactive Health Data Application. Alberta Government Are we speaking the same language? an argument for the consistent use of terminology and definitions for childhood vaccination indicators No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Decline in child vaccination coverage during the COVID-19 pandemic -Michigan Care Improvement Registry Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England Impact of the COVID-19 pandemic on administration of selected routine childhood and adolescent vaccinations -10 Impact of the COVID-19 pandemic on adolescent vaccinations: projected time to reverse deficits in routine adolescent vaccination in the United States Routine school immunizations to resume in July in South zone Vaccine coverage for kindergarteners: Factors associated with school and area variation in Vancouver, British Columbia Variation in exemptions to school immunization requirements among New York State private and public schools html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fvaccines%2Fcovid-19%2Finfo-by-product%2Fclinical-considerations.html#Coadministration 23. National Advisory Committee on Immunization. Recommendations on the use of COVID-19 vaccines. Government of Canada A public health timeline to prepare for COVID-19 vaccines in Canada This work was part of a larger project conducted by the COVImm study team. Hannah Sell: Conceptualization, methodology, data curation, software, formal analysis, investigation, visualization, writing -original draft and review & editing; Yuba Raj Paudel: Conceptualization, methodology, software, data curation, writing -review and editing, supervision; Donald Voaklander: Conceptualization, methodology, supervision, writing -review and editing; Shannon MacDonald: Conceptualization, methodology, funding acquisition, supervision, writing -review and editing. All authors have no conflicts of interest to disclose. This work was supported by an operating grant from the Canadian Institutes of Health Research (grant number: VR5-172700). HS received a WCHRI graduate studentship funded through the Stollery Children's Hospital Foundation through the Women and Children's Health Research Institute. The funding source had no role in the study design, data collection, analysis, or interpretation, the writing of the report, or in the decision to submit the paper for publication. The steward of the data used in this study is the Alberta Ministry of Health, who maintains the data for the purpose of health system administration. Thus, the authors are not at liberty to make the data publicly available. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.